Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.50 – $3.96
30% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $328.8M | $672.4M | $1.02B | $1.51B | $2.31B | $4.59B | $6.93B | $10.87B |
| Cost of revenue | $312.1M | $560.4M | $719.5M | $845.2M | $1.03B | $1.50B | $2.51B | $2.31B |
| Gross profit | $16.7M | $112.0M | $304.9M | $661.0M | $1.29B | $3.09B | $4.42B | $8.56B |
| Gross margin | 5.1% | 16.7% | 29.8% | 43.9% | 55.7% | 67.3% | 63.8% | 78.7% |
| R&D | $786.1M | $801.5M | $785.4M | $684.5M | $451.5M | $555.6M | $498.2M | $639.2M |
| Operating income | −$2.27B | −$2.54B | −$2.65B | −$2.74B | −$3.16B | −$2.12B | −$1.16B | $1.33B |
| EBITDA | −$285.0M | −$559.0M | $638.0M | $843.0M | $715.0M | −$2.12B | −$2.40B | $1.33B |
| Net income | −$2.55B | −$3.10B | −$2.01B | −$1.89B | −$2.45B | −$255.5M | −$2.50B | $4.15B |
| Net margin | -776.8% | -460.5% | -196.5% | -125.8% | -105.7% | -5.6% | -36.1% | 38.2% |
| EPS (diluted) | -97.41 | -103.36 | -49.65 | -37.20 | -40.64 | -3.49 | -25.20 | 31.28 |
Annual figures · source: Financial Modeling Prep
3-D MATRIX LTD
No one on the platform currently holds DMTRF.
No tracked institution reports a position in DMTRF as of their last filing.
No one on the platform has traded DMTRF yet.
| $144M |
| — |
| EDTXFSpectral Medical Inc | $0.95 | -1.04% | $262M | — |
| HNSBFHansa Biopharma AB | $2.90 | +0.00% | $246M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.